The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.
Can Long-Term Treatment With Antidepressant Drugs Worsen the Course of Depression?
Abstract
BACKGROUND: The possibility that antidepressant drugs, while effectively treating depression, may worsen its course has received inadequate attention. METHOD: A review of the literature suggesting potential depressogenic effects of long-term treatment with antidepressant drugs was performed. A MEDLINE search was conducted using the keywords tolerance, sensitization, antidepressive agents, and switching. This was supplemented by a manual search of Index Medicus under the heading "antidepressant agents" and a manual search of the literature for articles pointing to paradoxical effects of antidepressants. RESULTS: A number of reported clinical findings point to the following possibilities: very unfavorable long-term outcome of major depression treated by pharmacologic means, paradoxical (depression-inducing) effects of antidepressant drugs in some patients with mood and anxiety disturbances, antidepressant-induced switching and cycle acceleration in bipolar disorder, occurrence of tolerance to the effects of antidepressants during long-term treatment, onset of resistance upon rechallenge with the same antidepressant drug in a few patients, and withdrawal syndromes following discontinuation of mood-elevating drugs. These phenomena in susceptible individuals may be explained on the basis of the oppositional model of tolerance. Continued drug treatment may recruit processes that oppose the initial acute effects of a drug and may result in loss of clinical effect. When drug treatment ends, these processes may operate unopposed, at least for some time, and increase vulnerability to relapse. CONCLUSION: The possibility that antidepressant drugs may worsen the course of depression needs to be tested, even though its scientific exploration is likely to encounter considerable methodological and ideological difficulties. The clinical implications of this hypothesis in depression are considerable. Antidepressant drugs are crucial in the treatment of major depressive episodes. However, appraisal of paradoxical effects that may occur in susceptible patients during long-term treatment may lead to more effective use of the drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, this possibility runs counter the fact that the phenomenon is not generalized, since it involves a segment of the treated population that increases progressively over time.”
From May antidepressant drugs worsen the conditions they are supposed to treat? The clinical foundations of the oppositional model of tolerance (2020) · cites this paper as [15]
In the citing paper
“If we interpret the STAR*D findings in light of the oppositional tolerance model2,10,15: pharmacological manipulations, either by switching or augmentation may propel depressive illness into a more refractory phase, characterized by higher rates of relapse while on treatment, lower remission to subsequent treatments, as well as higher intolerance to further treatment (steps 3 and 4).”
From May antidepressant drugs worsen the conditions they are supposed to treat? The clinical foundations of the oppositional model of tolerance (2020) · cites this paper as [15]
In the citing paper
“According to the oppositional model of tolerance, continued drug treatment may recruit processes that oppose the initial acute effects of a drug.”
From Iatrogenic Factors in Psychopathology (2019) · cites this paper as [42]
In the citing paper
“Further, dosage increase is unlikely to restore response after loss of clinical effect [42].”
From Iatrogenic Factors in Psychopathology (2019) · cites this paper as [42]
In the citing paper
“This unnecessary prescription may lead to the development of dependence, onset of major depressive episode, withdrawal symptoms at discontinuation, persistent postwithdrawal disorder characterized by mood fluctuations and worsening of anxiety [41].”
From Iatrogenic Factors in Psychopathology (2019) · cites this paper as [42]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07492-2 · Cited by 7,007
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy.
Teasdale, J. D., Segal, Z. V., Williams, J. M. G., Ridgeway, V. A., Soulsby, J. M., & Lau, M. A. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.68.4.615 · Cited by 3,236
Habituation: A dual-process theory.
Groves, P. M., & Thompson, R. F. (1970) · Psychological Review · doi:10.1037/h0029810 · Cited by 2,161
Transduction of psychosocial stress into the neurobiology of recurrent affective disorder
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.8.999 · Cited by 1,848
Three-Year Outcomes for Maintenance Therapies in Recurrent Depression
Frank, E. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810240013002 · Cited by 1,297
Adult brain neurogenesis and psychiatry: a novel theory of depression
Jacobs, B. L., van Praag, H., & Gage, F. H. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000712 · Cited by 964
DEFINITION AND EPIDEMIOLOGY OF TREATMENT-RESISTANT DEPRESSION
Fava, M., & Davidson, K. G. (1996) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70283-5 · Cited by 797
Fava, M., & Kendler, K. S. (2000) · Neuron · doi:10.1016/s0896-6273(00)00112-4 · Cited by 603
HORMONE REPLACEMENT THERAPY, HEART DISEASE, AND OTHER CONSIDERATIONS
Barrett-Connor, E., & Grady, D. (1998) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.19.1.55 · Cited by 590
Tolerance and sensitization to the behavioral effects of drugs
Stewart, J., & Badiani, A. (1993) · Behavioural Pharmacology · doi:10.1097/00008877-199308000-00003 · Cited by 589
Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial
Rosenbaum, J. F., Fava, M., Hoog, S. L., Ascroft, R. C., & Krebs, W. B. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00126-7 · Cited by 574
Course of the Manic-Depressive Cycle and Changes Caused by Treatments
Kukopulos, A., Reginaldi, D., Laddomada, P., Floris, G., Serra, G., & Tondo, L. (2008) · Pharmacopsychiatry · doi:10.1055/s-2007-1019628 · Cited by 436
Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis
Hazell, P., O'Connell, D., Heathcote, D., Robertson, J., & Henry, D. (1995) · BMJ · doi:10.1136/bmj.310.6984.897 · Cited by 308
Six-Year Outcome for Cognitive Behavioral Treatment of Residual Symptoms in Major Depression
Fava, G. A., Rafanelli, C., Grandi, S., Canestrari, R., & Morphy, M. A. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.10.1443 · Cited by 299
Self-citationJarrett, R. B., Kraft, D., Doyle, J., Foster, B. M., Eaves, G. G., & Silver, P. C. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.4.381 · Cited by 293
Paykel, E. S., Hollyman, J. A., Freeling, P., & Sedgwick, P. (1988) · Journal of Affective Disorders · doi:10.1016/0165-0327(88)90075-4 · Cited by 273
Cognitive behavioral treatment of residual symptoms in primary major depressive disorder
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.9.1295 · Cited by 266
Self-citationShould depression be managed as a chronic disease?
Andrews, G. (2001) · BMJ · doi:10.1136/bmj.322.7283.419 · Cited by 260
Subclinical symptoms in mood disorders: pathophysiological and therapeutic implications
FAVA, G. A. (1999) · Psychological Medicine · doi:10.1017/s0033291798007429 · Cited by 258
Self-citationOutcome After Rapid vs Gradual Discontinuation of Lithium Treatment in Bipolar Disorders
Faedda, G. L. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820180046005 · Cited by 239
Remission and relapse in major depression: a two-year prospective follow-up study
Ramana, R., Paykel, E. S., Cooper, Z., Hayhurst, H., Saxty, M., & Surtees, P. G. (1995) · Psychological Medicine · doi:10.1017/s0033291700033134 · Cited by 236
A pilot study of cognitive therapy in bipolar disorders
SCOTT, J., GARLAND, A., & MOORHEAD, S. (2001) · Psychological Medicine · doi:10.1017/s0033291701003373 · Cited by 227
Segal, Z. V., Williams, J. M., Teasdale, J. D., & Gemar, M. (1996) · Psychological Medicine · doi:10.1017/s0033291700034760 · Cited by 227
Discontinuation Symptoms After Treatment With Serotonin Reuptake Inhibitors: A Literature Review
Zajecka, J., Tracy, K. A., & Mitchell, S. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0702 · Cited by 209
Reimherr, F. W., Amsterdam, J. D., Quitkin, F. M., Rosenbaum, J. F., Fava, M., Zajecka, J., Beasley, Jr., Michelson, D., Roback, P., & Sundell, K. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.9.1247 · Cited by 204
Time course of improvement under antidepressant treatment: A survival-analytical approach
Stassen, H. H., Delini-Stula, A., & Angst, J. (1993) · European Neuropsychopharmacology · doi:10.1016/0924-977x(93)90264-m · Cited by 191
Blackburn, I.-M., & Moore, R. G. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.171.4.328 · Cited by 179
Switch from Depression to Mania – A Record Study over Decades between 1920 and 1982
Angst, J. (1985) · Psychopathology · doi:10.1159/000284227 · Cited by 177
Lithium-discontinuation-induced refractoriness: preliminary observations
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.12.1727 · Cited by 163
Rapid cyclers, temperament, and antidepressants
Kukopulos, A., Caliari, B., Tundo, A., Minnai, G. P., Floris, G., Reginaldi, D., & Tondo, L. (1983) · Comprehensive Psychiatry · doi:10.1016/0010-440x(83)90076-7 · Cited by 161
Antidepressant Prescribing Practices of Outpatient Psychiatrists
Olfson, M., Marcus, S. C., Pincus, H. A., Zito, J. M., Thompson, J. W., & Zarin, D. A. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.4.310 · Cited by 161
Long-term outcome of panic disorder with agoraphobia treated by exposure
FAVA, G. A., RAFANELLI, C., GRANDI, S., CONTI, S., RUINI, C., MANGELLI, L., & BELLUARDO, P. (2001) · Psychological Medicine · doi:10.1017/s0033291701003592 · Cited by 156
Self-citationLoss of Antidepressant Efficacy During Maintenance Therapy: Possible Mechanisms and Treatments
Byrne, S. E., & Rothschild, A. J. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0602 · Cited by 149
Discontinuing antidepressant treatment in major depression.
Viguera, A. C., Baldessarini, R. J., & Friedberg, J. (1998) · Harvard Review of Psychiatry · doi:10.3109/10673229809003578 · Cited by 145
Antidepressant Withdrawal Syndrome: Recognition, Prevention and Management
Lejoyeux, M., Adès, J., Mourad, I., Solomon, J., & Dilsaver, S. C. (1996) · CNS Drugs · doi:10.2165/00023210-199605040-00006 · Cited by 136
Outcome of Depression in Psychiatric Settings
Piccinelli, M. P., & Wilkinson, G. (1994) · The British Journal of Psychiatry · doi:10.1192/bjp.164.3.297 · Cited by 131
Horwitz, R. I., Singer, B. H., Makuch, R. W., & Viscoli, C. M. (1996) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(95)00058-5 · Cited by 116
WITHDRAWAL SYMPTOMS FOLLOWING DISCONTINUATION OF IMIPRAMINE THERAPY
KRAMER, J. C., KLEIN, D. F., & FINK, M. (1961) · American Journal of Psychiatry · doi:10.1176/ajp.118.6.549 · Cited by 113
The Concept of Recovery in Affective Disorders
Fava, G. A. (2010) · Psychotherapy and Psychosomatics · doi:10.1159/000289025 · Cited by 113 · cited 1×
“ily the most suitable for postacute and residual phases or maintenance.(3) Different antidepressant drugs may yield a differential rate of tolerance in the long term, with particular reference to the HPA axis.”
BackgroundSelf-citationAnxiety and physical illness in the elderly.
Turnbull, J. M. (1989) · PubMed · Cited by 111
Otto, M. W., Pollack, M. H., & Sabatino, S. A. (1996) · Behavior Therapy · doi:10.1016/s0005-7894(96)80028-1 · Cited by 107
Evidence for a Sex-Specific Residual Effect of Cannabis on Visuospatial Memory
Pope, H. G., Jacobs, A. M., Mialet, J.-P., Yurgelun-Todd, D. A., & Gruber, S. A. (2010) · Psychotherapy and Psychosomatics · doi:10.1159/000289132 · Cited by 101
Hypomania and mania after withdrawal of tricyclic antidepressants
Mirin, S. M., Schatzberg, A. F., & Creasey, D. E. (1981) · American Journal of Psychiatry · doi:10.1176/ajp.138.1.87 · Cited by 95
Assessment of Psychological Distress in the Setting of Medical Disease
Fava, G. A., Mangelli, L., & Ruini, C. (2001) · Psychotherapy and Psychosomatics · doi:10.1159/000056249 · Cited by 94
Self-citationCognitive-Behavioral Management of Drug-Resistant Major Depressive Disorder
Fava, G. A., Savron, G., Grandi, S., & Rafanelli, C. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0608b · Cited by 92
Self-citationThe Antidepressant Web: Marketing depression and making medicines work
Medawar, C. (1997) · International Journal of Risk and Safety in Medicine · doi:10.3233/jrs-1997-10203 · Cited by 92
Prevalence and Clinical Correlates of Residual Depressive Symptoms in Bipolar II Disorder
Benazzi, F. (2001) · Psychotherapy and Psychosomatics · doi:10.1159/000056260 · Cited by 89
van Praag, H. M. (1996) · Psychiatry Research · doi:10.1016/s0165-1781(96)02923-x · Cited by 87
Is current treatment increasing asthma mortality and morbidity?
Mitchell, E. (1989) · Thorax · doi:10.1136/thx.44.2.81 · Cited by 86
Diefenbach, T. J., Sloley, B. D., & Goldberg, J. I. (1995) · Developmental Biology · doi:10.1006/dbio.1995.1023 · Cited by 83
Berendsen, H. H. G. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(94)00075-e · Cited by 82
Maj, M., Pirozzi, R., & Magliano, L. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.12.1810 · Cited by 80
Cognitive-Behavioral Therapy, Imipramine, or Their Combination for Panic Disorder
Barlow, D. H., Gorman, J. M., Shear, M. K., & Woods, S. W. (2020) · Routledge eBooks · doi:10.4324/9781315724539-11 · Cited by 76
Serotonin receptors and their function in sleep, anxiety disorders and depression
Leonard, B. E. (2010) · Psychotherapy and Psychosomatics · doi:10.1159/000289049 · Cited by 74
Do Antidepressant and Antianxiety Drugs Increase Chronicity in Affective Disorders?
Fava, G. A. (2010) · Psychotherapy and Psychosomatics · doi:10.1159/000288880 · Cited by 73
Self-citationLong-Term Treatment with Antidepressant Drugs: The Spectacular Achievements of Propaganda
Fava, G. A. (2002) · Psychotherapy and Psychosomatics · doi:10.1159/000056279 · Cited by 71
Self-citationLevodopa-Induced Neurotoxicity
Fahn, S. (1997) · CNS Drugs · doi:10.2165/00023210-199708050-00004 · Cited by 65
Noyes, R., Garvey, M. J., & Cook, B. L. (1989) · Journal of Affective Disorders · doi:10.1016/0165-0327(89)90080-3 · Cited by 65
Goldstein, T. R., Frye, M. A., Denicoff, K. D., Smith‐Jackson, E. E., Leverich, G. S., Bryan, A. L., Ali, O., & Post, R. M. (1999) · PubMed · Cited by 64
Relapse in patients on long-term fluoxetine treatment: response to increased fluoxetine dose.
D, M. F. M., Rappe, S., Pava, J. A., Nierenberg, A. A., Alpert, J. E., & Rosenbaum, J. F. (1995) · PubMed · Cited by 63
Rosholm, J.-U., Gram, L. F., Isacsson, G., Hallas, J., & Bergman, U. (1997) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050275 · Cited by 63
Antidepressants may not assist recovery in practice: a naturalistic prospective survey
Brugha, T. S., Bebbington, P., MacCarthy, B., Sturt, E., & Wykes, T. (1992) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1992.tb03218.x · Cited by 61
Fava, G. A., Bartolucci, G., Rafanelli, C., & Mangelli, L. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n07a10 · Cited by 61
Self-citationSchneider, G., Kruse, A., Nehen, H.-G., Senf, W., & Heuft, G. (2000) · Psychotherapy and Psychosomatics · doi:10.1159/000012404 · Cited by 60
Treatment Approaches to Major Depressive Disorder Relapse
Schmidt, M. E., Fava, M., Zhang, S., Gonzales, J., Raute, N. J., & Judge, R. (2002) · Psychotherapy and Psychosomatics · doi:10.1159/000063643 · Cited by 60
Tolerance to therapeutic effects of antidepressants
Cohen, B. M., & Baldessarini, R. J. (1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.4.489 · Cited by 57
Critical issues in the treatment of affective disorders
Brunello, N., Burrows, G. D., Jönsson, B., Judd, L. L., Kasper, S. F., Keller, M. B., Kupfer, D. J., Lecrubier, Y., Mendlewicz, J., Montgomery, S., et al. (1995) · Depression · doi:10.1002/depr.3050030406 · Cited by 57
Lithium Discontinuation and Subsequent Effectiveness
Coryell, W. H., Solomon, D., Leon, A. C., Akiskal, H. S., Keller, M. B., Scheftner, W. A., & Mueller, T. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.7.895 · Cited by 55
Sharma, V. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00212-3 · Cited by 54
Dawson, R., Lavori, P. W., Coryell, W. H., Endicott, J., & Keller, M. B. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(97)00181-x · Cited by 54
Conflict of Interest and Special Interest Groups
Fava, G. A. (2001) · Psychotherapy and Psychosomatics · doi:10.1159/000056218 · Cited by 53
Self-citationMaina, G., Albert, U., & Bogetto, F. (2001) · International Clinical Psychopharmacology · doi:10.1097/00004850-200101000-00004 · Cited by 52
Emergence of antidepressant induced suicidality
Healy, D. (2000) · Primary Care and Community Psychiatry · doi:10.1185/135525700543163 · Cited by 51
Cain, J. W. (1992) · PubMed · Cited by 49
Reducing Relapse in Depressed Outpatients with Atypical Features: A Pilot Study
Jarrett, R. B., Kraft, D., SCHAFFER, M. H., Witt-Browder, A., Risser, R. C., Atkins, D. H., & Doyle, J. (2000) · Psychotherapy and Psychosomatics · doi:10.1159/000012401 · Cited by 49
Continuation and Maintenance Treatments of Major Depressive Disorder
D, M. F. M., & Kaji, J. (1994) · Psychiatric Annals · doi:10.3928/0048-5713-19940601-07 · Cited by 49
Withdrawal Syndromes After Paroxetine and Sertraline Discontinuation
Fava, G. A., & Grandi, S. (1995) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199510000-00012 · Cited by 46
Self-citationTreatment Approaches to Major Depressive Disorder Relapse
Fava, M., Schmidt, M. E., Zhang, S., Gonzales, J., Raute, N. J., & Judge, R. (2002) · Psychotherapy and Psychosomatics · doi:10.1159/000063644 · Cited by 44
Tolerance in antidepressant treatment
Baldessarini, R. J., Ghaemi, S. N., & Viguera, A. C. (2002) · Psychotherapy and Psychosomatics · doi:10.1159/000063641 · Cited by 42 · cited 1×
“Several clinical observations point to the existence of tolerance phenomena during antidepressant treatment.(24,55)”
BackgroundAssay Sensitivity, Failed Clinical Trials, and the Conduct of Science
Otto, M. W., & Nierenberg, A. A. (2002) · Psychotherapy and Psychosomatics · doi:10.1159/000064813 · Cited by 42
Michelson, D., Amsterdam, J. D., Apter, J. T., Fava, M., Londborg, P. D., Tamura, R., & Pagh, L. M. (2000) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(99)00046-3 · Cited by 42
Effect of the serotonin antagonists ritanserin and ketanserin in Cushing’s disease
Sonino, N., Fava, G. A., Fallo, F., Franceschetto, A., Belluardo, P., & Boscaro, M. (2000) · Pituitary · doi:10.1023/a:1009986822146 · Cited by 41
Drug-Induced Switching in Bipolar Disorder: Epidemiology and Therapeutic Implications
Post, R. M., Denicoff, K. D., Leverich, G. S., & Frye, M. A. (1997) · CNS Drugs · doi:10.2165/00023210-199708050-00002 · Cited by 40
Effects of Imipramine on Individuals Varying in Level of Depression
DIMASCIO, A., MEYER, R. E., & STIFLER, L. (1968) · American Journal of Psychiatry · doi:10.1176/ajp.124.8s.55 · Cited by 39
Loss of drug effects during continuation therapy
Quitkin, F. M., Stewart, J. W., McGrath, P. J., Nunes, E. V., Ocepek‐Welikson, K., TRICAMO, E., Rabkin, J. G., Ross, D. G., & Klein, D. F. (1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.4.562 · Cited by 36
Heterocyclic antidepressant, monoamine oxidase inhibitor and neuroleptic withdrawal phenomena
Dilsaver, S. C. (1990) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(90)90097-z · Cited by 36
Holding On: Depression, Sensitization by Antidepressant Drugs, and the Prodigal Experts
Fava, G. A. (2010) · Psychotherapy and Psychosomatics · doi:10.1159/000288992 · Cited by 33 · cited 1×
“the risks and implications of interrupting maintenance psychotropic drug therapy(20) and developed in neurobiological terms.(21,22)”
BackgroundSelf-citationNeurobiologic Dimensions of Depression and Mania
Carroll, B. J. (1983) · Springer eBooks · doi:10.1007/978-3-642-69129-4_11 · Cited by 32
Fux, M., Taub, M., & Zohar, J. (1993) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1993.tb03448.x · Cited by 32
Risks and Implications of Interrupting Maintenance Psychotropic Drug Therapy
Baldessarini, R. J. (2010) · Psychotherapy and Psychosomatics · doi:10.1159/000288950 · Cited by 30
Tolerance to phenelzine and subsequent refractory depression: three cases.
Donaldson (1989) · PubMed · Cited by 26
Management of Major Depression in the Primary Care Setting
Mischoulon, D., McColl-Vuolo, R., Howarth, S., Lagomasino, I. T., Alpert, J. E., Nierenberg, A. A., & D, M. F. M. (2001) · Psychotherapy and Psychosomatics · doi:10.1159/000056233 · Cited by 24
Neurohypophyseal hormones in tolerance and physical dependence
Ritzmann, R. F., COLBERN, D. L., Zimmermann, E., & Krivoy, W. A. (1983) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(83)90017-7 · Cited by 23
Clinical application of time-dependent sensitization to antidepressant therapy
Antelman, S. M., & Gershon, S. (1998) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(97)00098-5 · Cited by 23
Potential Sensitising Effects of Antidepressant Drugs on Depression
Fava, G. A. (1999) · CNS Drugs · doi:10.2165/00023210-199912040-00001 · Cited by 23
Self-citationPsychomotor stimulant sensitization
Koob, G. F., & Cador, M. (1993) · Behavioural Pharmacology · doi:10.1097/00008877-199308000-00008 · Cited by 22
Olver, J. S., Burrows, G. D., & Norman, T. R. (1999) · CNS Drugs · doi:10.2165/00023210-199912030-00001 · Cited by 22
Withdrawal Hypomania Associated With Paroxetine
Landry, P., & Roy, L. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199702000-00016 · Cited by 20
Franchini, L., Rossini, D., Bongiorno, F., Spagnolo, C., Smeraldi, E., & Zanardi, R. (2000) · Psychiatry Research · doi:10.1016/s0165-1781(00)00188-8 · Cited by 20 · cited 1×
“It is conceivable that this proportion would have increased with continuation of the trial, as was found to be the case in recurrent depression.(59) These data, therefore, strongly point to pharmacodynamic tolerance.”
ResultModulation ofin vivo neuronal sprouting by serotonin in the adult CNS of the snail
Baker, M. W., & Croll, R. P. (1996) · Cellular and Molecular Neurobiology · doi:10.1007/bf02152057 · Cited by 19
Biondi, M. (2010) · Psychotherapy and Psychosomatics · doi:10.1159/000288985 · Cited by 16
Paradoxical mood shifts to euthymia or hypomania upon withdrawal of antidepressant agents.
McGrath, P. J., Jw, S., TRICAMO, E., En, N., & Quitkin, F. M. (1993) · PubMed · Cited by 16
Retreatment for relapse following desipramine discontinuation in dysthymia
Friedman, R. A., Mitchell, J., & Kocsis, J. H. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.6.926 · Cited by 15
Can long-term antidepressant use be depressogenic?
El-Mallakh, R. S., Waltrip, C., & Peters, C. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0412e · Cited by 14
Does fluoxetine have a therapeutic window?
Fichtner, C. G., Jobe, T. H., & Braun, B. (1991) · The Lancet · doi:10.1016/0140-6736(91)90599-k · Cited by 13
Antidepressants in Geriatric Depression:
Baldwin, R. (1995) · International Psychogeriatrics · doi:10.1017/s1041610295002353 · Cited by 13
Opportunistic ‘Rediscovery’ of Mental Disorders by the Pharmaceutical Industry
Starčević, V. (2002) · Psychotherapy and Psychosomatics · doi:10.1159/000065989 · Cited by 13
The metyrapone test in affective disorders and schizophrenia
Fava, G. A., Carson, S., Perini, G., Morphy, M. A., MOLNAR, G., & Jusko, W. J. (1984) · Journal of Affective Disorders · doi:10.1016/s0165-0327(84)80002-6 · Cited by 12
Self-citationRecurrent vital depressions. A follow-up study of 56 female and 28 male patients.
van Scheyen, J. D. (1973) · PubMed · Cited by 12
Fading of therapeutic effects of alprazolam in agoraphobia. Case reports
Fava, G. A. (1988) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(88)90066-8 · Cited by 11
Self-citationLong-acting β-Agonists, Tachyphylaxis, and Corticosteroids
Sears, M. R. (1996) · CHEST Journal · doi:10.1378/chest.109.4.862 · Cited by 11
Sonino, N., & Fava, G. A. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00252-x · Cited by 11
Self-citationTransient Mood Elevation Associated with Antidepressant Drug Decrease*
Corral, M., Sivertz, K., & Jones, B. D. (1987) · The Canadian Journal of Psychiatry · doi:10.1177/070674378703200906 · Cited by 11
The Changing Culture Related to the Practice of Psychiatry
Garfinkel, P. E. (2001) · Psychotherapy and Psychosomatics · doi:10.1159/000056259 · Cited by 10
Possible therapeutic window for serotonin reuptake inhibitors.
Fichtner, C. G., Jobe, T. H., & Braun, B. G. (1994) · PubMed · Cited by 10
The Treatment of Major Depressive Disorders
Wexler, B. E., & Nelson, J. C. (1993) · International Journal of Mental Health · doi:10.1080/00207411.1993.11449252 · Cited by 9
Journal Policies on Conflict of Interest
Rothman, K. J. (1993) · Science · doi:10.1126/science.8378766 · Cited by 9
Treatment-emergent depression with antidepressants in panic disorder
Aronson, T. A. (1989) · Comprehensive Psychiatry · doi:10.1016/0010-440x(89)90048-5 · Cited by 9
Therapeutic window for 5-HT reuptake inhibitors
Pitchot, W., Gonzalez-Moreno, A., & Ansseau, M. (1992) · The Lancet · doi:10.1016/0140-6736(92)90858-z · Cited by 8
A "Therapeutic Window" with Citalopram in a Case of Depression
Benazzi, F. (1996) · Pharmacopsychiatry · doi:10.1055/s-2007-979542 · Cited by 7
Young, L. T., Cooke, R. G., Levitt, A. J., & Joffe, R. T. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)00230-e · Cited by 6
Cited by
Deacon, B. J. (2013) · Clinical Psychology Review · doi:10.1016/j.cpr.2012.09.007 · Cited by 643
Treatment resistant depression: A multi-scale, systems biology approach
Akil, H., Gordon, J., Hen, R., Javitch, J., Mayberg, H., McEwen, B., Meaney, M. J., & Nestler, E. J. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.08.019 · Cited by 442
Buckman, J. E. J., Underwood, A., Clarke, K., Saunders, R., Hollon, S. D., Fearon, P., & Pilling, S. (2018) · Clinical Psychology Review · doi:10.1016/j.cpr.2018.07.005 · Cited by 398
“This is despite the suggestion that use of ADM may itself be a factor contributing to the risk of relapse or recurrence (Andrews, Kornstein, Halberstadt, Gardner, & Neale, 2011; Andrews, Thomson, Amstadter, & Neale, 2012; Fava, 2003).”
BackgroundMethodIncreasing Psychological Well‐Being and Resilience by Psychotherapeutic Methods
Fava, G. A., & Tomba, E. (2009) · Journal of Personality · doi:10.1111/j.1467-6494.2009.00604.x · Cited by 362
Self-citationEfficacy and effectiveness of antidepressants: current status of research
Pigott, H. E., Leventhal, A. M., Alter, G. S., & Boren, J. J. (2010) · Psychotherapy and Psychosomatics · doi:10.1159/000318293 · Cited by 347
Metadata
- Authors
- Fava, G. A.
- Affiliations
- University at Buffalo, State University of New York (US)
- Corresponding author
- Fava, Giovanni A.
- ORCID
- Fava, Giovanni A.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2003-02-15
- Volume
- 64
- Issue
- 2
- Pages
- 123-133
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2058326591
- Cited by
- 223
- References
- 121
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 9 · 2023: 6 · 2022: 7 · 2021: 7 · 2020: 9 · 2019: 12 · 2018: 11 · 2017: 10 · 2016: 9 · 2015: 6 · 2014: 11 · 2013: 9 · 2012: 12
- FWCI
- 7.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Social Sciences › Psychology › Clinical Psychology › Psychological Treatments and Disorders
- Keywords
- antidepressants, long-term antidepressant treatment, major depressive disorder, bipolar disorder, antidepressant resistance, withdrawal syndrome, relapse, drug sensitization
- MeSH terms
- Acute Disease, Antidepressive Agents, Bipolar Disorder, Depressive Disorder, Drug Administration Schedule, Drug Resistance, Drug Tolerance, Humans, Pharmacology, Clinical, Recurrence, Substance Withdrawal Syndrome, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.